The impact of respiratory diseases on quality of life since the pandemic: a dual perspective based on objective consumption upgrading and subjective well-being
摘要
The COVID-19 pandemic has exacerbated the global burden of respiratory diseases (RD), intensifying syndemic threats and the “immunity debt” effect. However, evidence gaps persist regarding RD impacts on Quality of Life (QoL) and socioeconomic disparities in the post-pandemic context.
MethodsCross-sectional data from the 2022 China Family Panel Studies (CFPS) covered Chinese residents aged 15–89. Surveys were conducted from May to December 2022. QoL was assessed via Consumption Upgrading Index (CUI) and Subjective Well-Being (SWB). Regression models, Propensity Score Matching (PSM), and mediation/moderation analyses examined RD-QoL relationships.
Results(1) RD prevalence reached 39.94% in 2022 (a 1.29-percentage-point increase from 2020). (2) RD showed significant negative correlations with QoL, reducing both CUI and SWB. (3) Subgroup analyses revealed greater CUI reductions among males, rural residents, the unemployed, and Eastern China residents; more pronounced SWB declines occurred among females and Eastern residents. (4) Pandemic incidence exacerbated RD’s negative impact on CUI (particularly for females). (5) Hospitalization (health mediator) and reduced non-medical spending (economic mediator) were core pathways.
ConclusionsPost-pandemic RD burden creates “dual deprivation” of QoL, undermining economic resilience and mental health. Policies addressing sex/urban-rural disparities and strengthening integrated health-economic safeguards are needed.